Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZXZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,650
Award facts
- Contract value 100% obligated
- $38,650.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,650.25 delivery order to AmerisourceBergen Drug Corp for Cosentyx SensoReady 150 mg pen/mL pharmaceutical products, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, reflecting the strategic importance of this supplier relationship to federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4ZXZ?
SPE2DR26F4ZXZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F4ZXZ worth?
The government has obligated $38,650 on SPE2DR26F4ZXZ.
Is contract SPE2DR26F4ZXZ an order under another contract?
Yes. SPE2DR26F4ZXZ is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZXZ competed?
The extent of competition for SPE2DR26F4ZXZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award